The Annual Meeting Planning Committee has developed a robust program featuring expert speakers in all facets of rheumatology. Over the next several days, ACR Convergence participants from around the world will delve into recent breakthroughs in the foundational science and clinical care of rheumatology, as…
Kevin Winthrop, MD, MPH, discussed how a warming climate is influencing infectious disease exposure and contributing to a range of musculoskeletal and immune-mediated consequences.
A three-person panel, including Yike Jiang, MD, will showcase how these tools can help rheumatologists better understand the underlying causes of diagnoses and refine how clinicians think about medicine.
Michael Weintraub, MD, and Veena K. Ranganath, MD, MS, RhMSUS, will discuss the evolving landscape of glucagon-like peptide-1 receptor agonists and current evidence for the use of this kind of incretin therapy in rheumatologic diseases.
The Pediatric and Adult Thieves Market sessions offer valuable insights on evaluating complex cases, building a differential diagnosis, and determining a treatment approach. A rigorous peer review process determines the four fellows who present in each session.
During the debate—one of three Great Debates at ACR Convergence 2026—attendees will have the opportunity to compare data and perspectives from leading experts from Europe and the United States on the risks and benefits of lip biopsies for diagnosing patients with this autoimmune disease.
POSTER: Jessica Fairley, PhD, MBBS (Hons), FRACP